AAAAAA
Results: 26-37/37
Authors:
Gasnault, J
Taoufik, Y
Goujard, C
Kousignian, P
Abbed, K
Boue, F
Dussaix, E
Delfraissy, JF
Citation: J. Gasnault et al., Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy, J NEUROVIRO, 5(4), 1999, pp. 421-429
Authors:
Zou, WP
Foussat, A
Houhou, S
Durand-Gasselin, I
Dulioust, A
Bouchet, L
Galanaud, P
Levy, Y
Emilie, D
Aboulker, JP
Capitant, C
Boue, F
Bouvet, E
Karmochkinc, M
Kazatchkine, M
Oksenhendler, E
Viard, JP
Weiss, L
Yeni, P
Delfraissy, JF
Goujard, C
Jarrousse, B
Lepeu, G
Cartier, F
Bazin, C
Six, M
Gastaut, JA
Seligmann, M
Herrerra, A
Maral, J
Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463
Authors:
Martinon, F
Michelet, C
Peguillet, I
Taoufik, Y
Lefebvre, P
Goujard, C
Guillet, JG
Delfraissy, JF
Lantz, O
Citation: F. Martinon et al., Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy, AIDS, 13(2), 1999, pp. 185-194
Authors:
Blanche, S
Tardieu, M
Rustin, P
Slama, A
Barret, B
Firtion, G
Ciraru-Vigneron, N
Lacroix, C
Rouzioux, C
Mandelbrot, L
Desguerre, I
Rotig, A
Mayaux, MJ
Delfraissy, JF
Citation: S. Blanche et al., Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues, LANCET, 354(9184), 1999, pp. 1084-1089
Authors:
Levy, Y
Capitant, C
Houhou, S
Carriere, I
Viard, JP
Goujard, C
Gastaut, JA
Oksenhendler, E
Boumsell, L
Gomard, E
Rabian, C
Weiss, L
Guillet, JG
Delfraissy, JF
Aboulker, JP
Seligmann, M
Citation: Y. Levy et al., Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, LANCET, 353(9168), 1999, pp. 1923-1929
Authors:
Dalod, M
Dupuis, M
Deschemin, JC
Sicard, D
Salmon, D
Delfraissy, JF
Venet, A
Sinet, M
Guillet, JG
Citation: M. Dalod et al., Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy, J VIROLOGY, 73(9), 1999, pp. 7108-7116
Authors:
Meyer, L
Magierowska, M
Hubert, JB
Mayaux, MJ
Misrahi, M
Le Chenadec, J
Debre, P
Rouzioux, C
Delfraissy, JF
Theodorou, I
Citation: L. Meyer et al., CCR5 Delta 32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1, J INFEC DIS, 180(3), 1999, pp. 920-924
Authors:
Levy, A
Laska, F
Abelhauser, A
Delfraissy, JF
Goujard, C
Boue, F
Dormant, J
Citation: A. Levy et al., Disclosure of HIV seropositivity, J CLIN PSYC, 55(9), 1999, pp. 1041-1049
Authors:
Dalod, M
Dupuis, M
Deschemin, JG
Goujard, C
Deveau, C
Meyer, L
Ngo, N
Rouzioux, C
Guillet, JG
Delfraissy, JF
Sinet, M
Venet, A
Citation: M. Dalod et al., Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection, J CLIN INV, 104(10), 1999, pp. 1431-1439
Authors:
Michelet, C
Bellissant, E
Ruffault, A
Arvieux, C
Delfraissy, JF
Raffi, F
Bazin, C
Renard, I
Sebille, V
Chauvin, JP
Dohin, E
Cartier, F
Citation: C. Michelet et al., Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine, CLIN PHARM, 65(6), 1999, pp. 661-671
Authors:
Follezou, JY
Lan, NY
Lien, TX
Lafon, ME
Tram, LT
Hung, PV
Aknine, X
Lowenstein, W
Ngai, V
Theodorou, I
Delfraissy, JF
Debre, P
Fleury, HJA
Barre-Sinoussi, F
Chi, NH
Citation: Jy. Follezou et al., Clinical and biological characteristics of human immunodeficiency virus-infected and uninfected intravascular drug users in Ho Chi Minh City, Vietnam, AM J TROP M, 61(3), 1999, pp. 420-424
Authors:
Taoufik, Y
Gasnault, J
Karaterki, A
Ferey, MP
Marchadier, E
Goujard, C
Lannuzel, A
Delfraissy, JF
Dussaix, E
Citation: Y. Taoufik et al., Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy, J INFEC DIS, 178(6), 1998, pp. 1816-1820